🔎 Trials Near Me

Domov › Nemalicelični pljučni rak › Ohio › Cleveland

Klinične študije za Nemalicelični pljučni rak v Cleveland, OH

43 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Cleveland in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Vključevanje udeležencevFaza 3
  • MetroHealth Medical Center, Cleveland
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • in še 2
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT04267848

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Vključevanje udeležencevFaza 1
  • University Hospitals Cleveland Medical Center, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Vključevanje udeležencevFaza 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 1/2
  • Research Site, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06996782

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Vključevanje udeležencevFaza 1
  • Exelixis Clinical Site #10, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT05176483

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Vključevanje udeležencevFaza 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
  • Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07361497

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center at Chagrin Highlands, Orange · 12 mi stran
  • University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor · 22 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07144280

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • University Hospitals Cleveland Medical Center, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07222566

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 2
  • University Hospitals Cleveland Medical Center, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06667908

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Vključevanje udeležencevFaza 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center at Chagrin Highlands, Orange · 12 mi stran
  • University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor · 22 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06758401

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • Fairview Hospital, Cleveland
  • Cleveland Clinic, Cleveland
  • Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06890598

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2
  • Cleveland Clinic, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT06618287

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 2
  • Research Site, Cleveland
Starost 18–95 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05061550

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Vključevanje udeležencevFaza 2
  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07104630

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Vključevanje udeležencevFaza 2/3
  • The Cleveland Clinic Cancer Center At Fairview Hospital, Moll Pavilion, Cleveland
  • Cleveland Clinic, Cleveland
  • Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06712316

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Vključevanje udeležencevFaza 2/3
  • University Hospitals Cleveland Medical Center, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07100080

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Vključevanje udeležencevFaza 3
  • Clinical Study Site, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT06767514

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Vključevanje udeležencevFaza 1/2
  • Cleveland Clinic, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT05786924

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Vključevanje udeležencevFaza 2/3
  • University Hospitals Cleveland Medical Center, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT04613596

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Vključevanje udeležencevOpazovalna študija
  • Cleveland Clinic, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05059444

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Vključevanje udeležencevFaza 1
  • University Hospital Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06253871

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

Vključevanje udeležencevFaza 1/2
  • Case Western Reserve University, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07012031

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 1
  • Cleveland Clinic, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06343402

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Vključevanje udeležencevFaza 1
  • Cleveland Clinic, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT04913285

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Vključevanje udeležencevFaza 1/2
  • Cleveland Clinic Taussig Cancer Center, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07070232

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Vključevanje udeležencevFaza 1/2
  • Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT06892548

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Vključevanje udeležencevFaza 1
  • Cleveland Clinic, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT06586515

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • Cleveland Clinic Taussig Cancer Institute, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT06774963

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 1/2
  • Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT07111520

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • University Hospital - Cleveland Medical Center, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT07444814

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • University Hospitals Cleveland Medical Center, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT05208762

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Vključevanje udeležencevFaza 1/2
  • University Hospitals Cleveland, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 21. jul. 2026 · NCT05098132

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Vključevanje udeležencevFaza 1/2
  • University Hospitals Cleveland Medical Center, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 30. jun. 2026 · NCT06162221

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1
  • Research Site, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 12. jun. 2026 · NCT07284186

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Vključevanje udeležencevFaza 1
  • University Hospitals - UH Cleveland Medical Center, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 18. maj 2026 · NCT07094204

A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 1/2
  • Gabrail Cancer Center, Ohio City · 1 mi stran
Starost 19 in več · Vsi spoli · Posodobljeno 27. apr. 2026 · NCT07439094

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Vključevanje udeležencev
  • Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 19. feb. 2026 · NCT02984761

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1/2
  • Cleveland Clinic, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 18. feb. 2026 · NCT07030257

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Vključevanje udeležencevOpazovalna študija
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi stran
Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Vključevanje udeležencevFaza 1/2
  • Cleveland Clinic, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 24. okt. 2025 · NCT06228326

A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 2
  • Cleveland Clinic, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2025 · NCT06868485

Študije za Nemalicelični pljučni rak v drugih mestih

Druge študije v Cleveland

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.